Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an <sup>18</sup>F-Labeled Analogue of the MDM2 Inhibitor SP-141

Murine double minute 2 (MDM2), a negative regulator of the p53 tumor suppressor protein, is overexpressed in several human cancers. Herein we investigate the feasibility of developing <sup>18</sup>F-labeled compounds based on the small molecule inhibitor SP-141 for imaging tumor MDM2 exp...

Full description

Bibliographic Details
Main Authors: Satish K. Chitneni, Zhengyuan Zhou, Brian E. Watts, Michael R. Zalutsky
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Pharmaceuticals
Subjects:
PET
Online Access:https://www.mdpi.com/1424-8247/14/4/358